Cutaneous reactions caused by injected immunomodulators in the treatment of multiple sclerosis and associated factors.

Objectives: to describe cutaneous reactions caused by injected immunomodulators used for the treatment of multiple sclerosis (MS) and associated factors. Methods: a descriptive and analytical cross-sectional study was conducted with a nonprobability sample of MS patients undergoing treatment at a ho...

Descripción completa

Detalles Bibliográficos
Publicado en:Revista Eletrônica de Enfermagem Vol. 27; pp. 1 - 9
Autores principales: de Oliveira, Ligia Nogueira Manso, Miot, Hélio Amante, Saranholi, Tais Lopes, Abbade, Luciana Patrícia Fernandes
Formato: research tables/charts Journal Article
Publicado: Revista Eletronica de Enfermagem 2025
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=192467738&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 192467738
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        15181944
        1D2L
      jtl: Revista Eletrônica de Enfermagem
      issn: 15181944
      maglogo: N
    pubinfo:
      dt: 2025
      vid: 27
      pid: 24818
      pub: Revista Eletronica de Enfermagem
    artinfo:
      ui:
        192467738
        192467738
        192467738
        10.5216/ree.v27.76957
        192467738
      ppf: 1
      ppct: 8
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: Cutaneous reactions caused by injected immunomodulators in the treatment of multiple sclerosis and associated factors.
      aug:
        au:
          de Oliveira, Ligia Nogueira Manso
          Miot, Hélio Amante
          Saranholi, Tais Lopes
          Abbade, Luciana Patrícia Fernandes
        affil: Universidade Estadual Paulista Júlio de Mesquita Filho (Unesp), Botucatu, São Paulo, Brazil
      sug:
        subj:
          Multiple Sclerosis Drug Therapy
          Immunologic Factors Administration and Dosage
          Immunologic Factors Adverse Effects
          Injections, Subcutaneous Adverse Effects
          Dermatitis Medicamentosa Risk Factors
          Drug Hypersensitivity
          Risk Assessment
          Brazil
          Human
          Male
          Female
          Adult
          Middle Age
          Descriptive Research
          Analytic Research
          Cross Sectional Studies
          Academic Medical Centers Brazil
          Nonprobability Sample
          Convenience Sample
          Structured Interview
          Fisher's Exact Test
          Parametric Statistics
          Mann-Whitney U Test
          Kruskal-Wallis Test
          P-Value
          T-Tests
          Data Analysis Software
          Descriptive Statistics
          Hyperemia
          Sclerosis
          Ecchymosis
          Edema
          Depression
          Obesity
          Adult: 19-44 years
          Middle Aged: 45-64 years
          Male
          Female
      ab: Objectives: to describe cutaneous reactions caused by injected immunomodulators used for the treatment of multiple sclerosis (MS) and associated factors. Methods: a descriptive and analytical cross-sectional study was conducted with a nonprobability sample of MS patients undergoing treatment at a hospital's neuroimmunology center. The data were collected using structured interviews consisting of two instruments. Results: the sample consisted of 116 MS patients with an average age of 39.8 years, who were predominantly female (72.4%) and white (98.3%). The most prevalent type of MS was relapsing-remitting MS (70.0%). A total of 101 (87.0%) participants developed one or more cutaneous reactions at the injection site. The most frequent reactions were hyperemia (n = 86; 74%), sclerosis (n = 68; 59%), ecchymosis (n = 59; 51%), oedema (n = 53; 46%) and warmth (n = 50; 43%). Reactions were mostly mild and moderate intensity. The factors associated with reactions were depression (p = 0.01) and Body Mass Index considered to be obese (p = 0.04). Conclusions: a significant proportion of patients developed cutaneous reactions at the immunomodulator injection site, and the presence of reactions was associated with depression and obesity.
      pubtype: Academic Journal
      doctype:
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N